Autoimmune Diseases

IWBCA
Feb 7
34 min read

Autoimmune diseases occur when the immune system, which normally protects you from infections and harmful substances, misidentifies parts of your own body as a threat and attacks them. These conditions can involve almost any organ system and often unfold over years. There is currently no cure, but many treatments can reduce inflammation, control overactive immune responses, and help people maintain function and quality of life.

Overview

What is an autoimmune disease?

Autoimmune diseases are a group of chronic conditions in which the immune system targets the body’s own cells, tissues, or organs rather than responding to genuine threats such as viruses, bacteria, or toxins. In a healthy state, the immune system functions as a highly coordinated surveillance and response network: it recognizes foreign substances, activates white blood cells and antibodies, and clears invaders before they can cause damage. In autoimmunity, some components of this system become misdirected. Immune cells and antibodies that should ignore “self” structures instead react against them, driving inflammation and tissue injury.

This process can be organ-specific, affecting mainly one area (for example, the pancreas in type 1 diabetes or the thyroid in Hashimoto’s thyroiditis), or systemic, involving multiple organs at once (as in systemic lupus erythematosus or vasculitis). Symptoms can range from mild and intermittent to severe, disabling, and life-threatening. Many autoimmune diseases fluctuate over time, with periods of increased disease activity alternating with quiescent phases. Because these conditions tend to persist for years, they are generally considered chronic illnesses that require ongoing monitoring, treatment, and self-management.

Autoimmune diseases arise from a combination of factors rather than a single cause. Genetics can increase susceptibility, particularly when multiple family members have autoimmune conditions. Environmental triggers such as infections, certain medications, tobacco use, stress, diet, and hormone shifts may influence when or how the disease appears. The immune system’s regulation and “tolerance” mechanisms, which normally prevent attacks on the body’s own tissues, are often altered in subtle ways. Research is ongoing to better understand these interactions and to develop therapies that more precisely calm harmful immune responses while preserving essential defenses.

Categorization

How many types of autoimmune diseases are there?

There are more than 100 recognized autoimmune diseases and closely related conditions. They can affect nearly any tissue or organ system, sometimes in isolation and sometimes in overlapping patterns. Many people live with more than one autoimmune diagnosis.

Organ systems commonly involved include the:

Joints and Muscles

Rheumatoid Arthritis: A chronic inflammatory arthritis that primarily affects the small joints of the hands, wrists, and feet, causing pain, prolonged morning stiffness, swelling, and, over time, joint damage and deformity if not treated. It can also involve tendons, blood vessels, lungs, and eyes.
Systemic Lupus Erythematosus: A systemic autoimmune disease that often presents with joint pain and stiffness, fatigue, and characteristic rashes, but can also involve the kidneys, blood, nervous system, and serosal surfaces. Joint inflammation is usually non-erosive but can be disabling during flares.
Inflammatory Myopathies (Polymyositis and Dermatomyositis): A group of diseases characterized by immune-mediated muscle inflammation and weakness, typically affecting muscles of the shoulders, hips, and neck. Dermatomyositis includes distinctive skin rashes, while both conditions may be associated with lung disease, cardiac involvement, and, in some cases, underlying malignancy.
Psoriatic Arthritis: An inflammatory arthritis associated with psoriasis that can affect peripheral joints, the spine, and entheses (sites where tendons and ligaments attach to bone). It may cause swelling of entire fingers or toes (“dactylitis”), nail changes, and can lead to joint damage if not treated.

Skin and Blood Vessels

Psoriasis: A chronic inflammatory skin disease that causes well-defined, thick, scaly plaques, often on the scalp, elbows, knees, and trunk. It is associated with systemic inflammation and can be linked to arthritis, metabolic syndrome, and increased cardiovascular risk.
Vitiligo: An autoimmune condition in which melanocytes (pigment-producing cells) are destroyed, leading to sharply demarcated areas of depigmented skin. It can occur alone or in association with other autoimmune diseases, particularly autoimmune thyroid disease.
Systemic Sclerosis (Scleroderma): A connective tissue disease characterized by immune-mediated damage to small blood vessels and excessive collagen deposition in the skin and internal organs. It can cause skin thickening, Raynaud’s phenomenon, digital ulcers, gastrointestinal dysmotility, lung fibrosis, and pulmonary hypertension.
Cutaneous and Systemic Forms of Lupus: Cutaneous lupus includes skin-limited manifestations such as discoid lesions or photosensitive rashes. Systemic lupus erythematosus involves both the skin and internal organs and is characterized by rashes, ulcers, hair loss, joint inflammation, kidney disease, neurologic involvement, and hematologic abnormalities.
Primary Sjögren’s Disease: An autoimmune disease in which the immune system targets the tear and salivary glands, causing dry eyes, dry mouth, dental problems, and sometimes swelling of salivary glands. It can also involve joints, nerves, lungs, and kidneys, and increase the risk of lymphoma.
Vasculitides: A group of disorders characterized by immune-mediated inflammation and damage of blood vessel walls. Depending on the vessel size and distribution, these diseases can cause sinus and lung disease, kidney inflammation, headaches, jaw claudication, vision loss, nerve damage, abdominal pain, and organ ischemia.
Urticarial Vasculitis and Rheumatoid Vasculitis: Urticarial vasculitis presents with hive-like lesions that last longer than typical hives and may leave bruising or pigmentation, reflecting small-vessel inflammation. Rheumatoid vasculitis is a severe extra-articular manifestation of longstanding rheumatoid arthritis that affects small and medium vessels, leading to skin ulcers, neuropathy, and organ damage.

Digestive System

Crohn’s Disease: A chronic inflammatory bowel disease that can affect any part of the gastrointestinal tract from the mouth to the anus, causing abdominal pain, diarrhea, weight loss, and sometimes strictures, fistulas, and perianal disease. It is associated with extraintestinal manifestations, including joint pain, ocular inflammation, and skin lesions.
Ulcerative Colitis: An inflammatory bowel disease primarily affecting the colon and rectum, leading to bloody diarrhea, urgency, abdominal cramping, and tenesmus. It can also be associated with joint, skin, liver, and eye involvement and carries an increased risk of colorectal cancer over time.
Celiac Disease: An immune-mediated enteropathy triggered by gluten in genetically susceptible individuals. It damages the small intestinal mucosa, causing malabsorption, diarrhea, bloating, iron deficiency, bone loss, and, in some cases, subtle symptoms such as fatigue or anemia.
Autoimmune Hepatitis and Primary Biliary Cholangitis: Autoimmune hepatitis involves immune-mediated inflammation of the liver parenchyma, leading to elevated liver enzymes, fatigue, and risk of cirrhosis if untreated. Primary biliary cholangitis targets small intrahepatic bile ducts, causing cholestasis, pruritus, fatigue, and progressive liver damage.
Autoimmune Gastritis: A chronic inflammation of the stomach lining driven by autoantibodies against parietal cells or intrinsic factor. It can lead to reduced gastric acid secretion, vitamin B12 deficiency, iron-deficiency anemia, and an increased risk of gastric neoplasia.

Endocrine (Hormone) System

Type 1 Diabetes: An autoimmune destruction of pancreatic beta cells that leads to absolute insulin deficiency. It typically presents with excessive thirst, frequent urination, weight loss, and fatigue, and requires lifelong insulin therapy to prevent acute complications (such as ketoacidosis) and long-term damage to eyes, kidneys, nerves, and blood vessels.
Hashimoto’s Thyroiditis (Autoimmune Hypothyroidism): A common cause of underactive thyroid function, characterized by lymphocytic infiltration of the thyroid gland and anti-thyroid antibodies. Symptoms can include fatigue, weight gain, cold intolerance, constipation, hair loss, and depression, and it is treated with thyroid hormone replacement.
Graves’ Disease (Autoimmune Hyperthyroidism): An autoimmune condition in which antibodies stimulate the thyroid gland to produce excess hormone, leading to weight loss, heat intolerance, palpitations, anxiety, tremor, and sometimes eye involvement (Graves’ orbitopathy). Treatment may include antithyroid medications, radioactive iodine, or surgery.
Addison’s Disease (Primary Adrenal Insufficiency): Autoimmune destruction of the adrenal cortex that results in deficiency of cortisol and often aldosterone. Patients may experience fatigue, weight loss, low blood pressure, dizziness, salt craving, hyperpigmentation, and risk of life-threatening adrenal crisis if not treated with hormone replacement.
Autoimmune Polyglandular Syndromes: Clusters of autoimmune endocrine diseases that occur together, such as combinations of type 1 diabetes, autoimmune thyroid disease, Addison’s disease, and others. These syndromes reflect broader immune dysregulation and require coordinated, multisystem management.

Nervous System

Multiple Sclerosis: A chronic demyelinating disease of the central nervous system in which immune cells attack myelin and nerve fibers. It can cause visual disturbances, limb weakness, numbness, balance problems, bladder dysfunction, and cognitive changes, often with a relapsing–remitting course.
Myasthenia Gravis: An autoimmune disease affecting the neuromuscular junction, leading to fluctuating muscle weakness that worsens with activity and improves with rest. Common features include drooping eyelids, double vision, difficulty chewing or swallowing, and generalized fatigue.
Guillain–Barré Syndrome: An acute, often post-infectious neuropathy in which the immune system attacks peripheral nerves, causing rapidly progressive weakness, sensory changes, and in severe cases, respiratory failure. It is a medical emergency requiring prompt treatment and monitoring.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A chronic, relapsing or progressive inflammatory neuropathy characterized by symmetric weakness and sensory loss in the limbs. It typically evolves over at least eight weeks and can cause significant disability if not treated with immunomodulatory therapies.
Autoimmune Encephalitis in Specific Antibody-Mediated Disorders: A group of conditions in which antibodies target neuronal or synaptic proteins in the brain, leading to seizures, memory loss, psychiatric symptoms, abnormal movements, and altered consciousness. Early recognition and immunotherapy are critical to improve outcomes.

Autoimmune conditions can also significantly involve the blood, kidneys, lungs, and heart, as in systemic lupus erythematosus, antiphospholipid syndrome, and systemic vasculitis. Because of this diversity and the potential for multi-organ involvement, autoimmune diseases are often managed by a coordinated team of specialists that may include rheumatologists, neurologists, gastroenterologists, endocrinologists, dermatologists, nephrologists, cardiologists, pulmonologists, and immunologists, with care tailored to the organs affected and the severity of disease.

Prevalence

How common are autoimmune diseases?

Autoimmune diseases are collectively common, even though individual conditions may be relatively rare. Recent large electronic-health-record and registry analyses in the United States suggest that at least 4% to 8% of the population has been diagnosed with one or more autoimmune diseases, which translates into tens of millions of people, and many experts believe these figures underestimate the true burden because of underdiagnosis and misclassification in primary care. Data from national and global burden-of-disease studies indicate that the age-standardized prevalence of autoimmune diseases has risen substantially over the past three decades, with year-on-year increases in both incidence and prevalence across multiple conditions. When all autoimmune diseases are considered together, they are now described as one of the most common categories of chronic illness worldwide, alongside cardiovascular disease and cancer, and a major driver of long-term disability and healthcare utilization.

From a women’s health perspective, autoimmunity is especially significant. Across cohorts, women account for roughly two-thirds to nearly four-fifths of all people living with autoimmune disease, with an overall female-to-male ratio of about 2 to 1 and far higher sex gaps in specific conditions such as lupus, Sjögren’s disease, and autoimmune thyroid disease. The burden is particularly concentrated in women during the reproductive and perimenopausal years, when hormonal transitions, pregnancy, and postpartum shifts intersect with immune vulnerability and can influence both disease onset and flare patterns. Emerging data also show that certain gynecologic conditions, such as premature ovarian insufficiency, are linked with substantially higher rates of later autoimmune diagnoses, underscoring the need to integrate autoimmune risk assessment into women’s healthcare, not just rheumatology and neurology clinics. Because there are more than a hundred distinct autoimmune diagnoses and classification criteria continue to evolve, it remains challenging to pin down a single exact prevalence figure. What is clear is that autoimmunity represents a central, and often under-recognized, pillar of chronic disease in women, making early recognition, accurate diagnosis, and individualized treatment a core women’s health priority as well as a broader public health need.

Symptoms

What are the most common symptoms associated with autoimmune conditions?

Autoimmune diseases can involve almost any organ system, so symptoms vary widely from one person to another. Many conditions share a core set of systemic symptoms and then add organ-specific features depending on the tissues targeted. In women, these symptoms often overlap with menstrual changes, pregnancy, postpartum recovery, and perimenopause, which can mask early disease and delay diagnosis.

Common systemic symptoms include:

Persistent Fatigue

A level of tiredness that does not match daily activity and is not relieved by rest or sleep. People often describe feeling “wiped out” by routine tasks, needing frequent naps, or waking unrefreshed despite a full night’s sleep. This fatigue can interfere with work, caregiving responsibilities, and social activities and is among the most commonly underrecognized features of autoimmune disease.

Low-Grade Fevers or “Flu-Like” Feelings

Recurrent low fevers, chills, or a generalized “coming down with something” sensation without a clear infection. These episodes may come and go, often worsening later in the day or during flares, and may be dismissed as minor viral illnesses even when they reflect ongoing immune activation.

Generalized Pain and Stiffness

Diffuse muscle aching, joint discomfort, and a heavy, unwell feeling that can move from place to place. Stiffness is often most noticeable in the morning or after periods of rest and may improve somewhat with gentle movement, a pattern that can help distinguish inflammatory pain from purely mechanical or overuse pain.

Unintentional Weight Change

Weight loss without dieting, often accompanied by loss of appetite, nausea, or gastrointestinal symptoms, may indicate uncontrolled inflammation, endocrine dysfunction, or intestinal disease. Less commonly, weight gain can occur due to reduced activity from pain and fatigue, fluid retention, or autoimmune conditions that slow metabolism, such as hypothyroidism.

Organ-specific patterns can include:

Joints and Muscles

Joint pain, warmth, swelling, and morning stiffness lasting 30 to 60 minutes, particularly in the hands, wrists, feet, or knees, are classic signs of inflammatory arthritis, including rheumatoid arthritis and psoriatic arthritis. Over time, these symptoms can lead to decreased grip strength, difficulty with fine motor tasks, and visible joint changes. Muscle involvement may present as true weakness rather than pain, with individuals noticing difficulty climbing stairs, rising from low chairs, lifting children or groceries, or holding their arms up to style their hair, as occurs in inflammatory myopathies.

Skin, Hair, and Mucous Membranes

Skin changes can include rashes that worsen with sun exposure (as in lupus), thick, scaly plaques (as in psoriasis), or areas of skin that lose pigment (as in vitiligo). Some women notice painful or recurrent mouth or nose ulcers, cracking at the corners of the lips, or a burning sensation on the tongue. Pronounced dryness of the eyes or mouth, difficulty swallowing dry foods, frequent dental cavities, or a gritty feeling in the eyes may suggest Sjögren’s disease. Hair can become thinner overall or shed in patches, which is often distressing and may be among the first visible clues of autoimmunity.

Endocrine and Metabolic Symptoms

Autoimmune thyroid disease can cause a broad range of symptoms, including fatigue, weight gain, constipation, feeling cold, and hair loss when thyroid function is low; and weight loss, heat intolerance, rapid heartbeat, anxiety, and tremor when thyroid function is high. Type 1 diabetes can present with intense thirst, frequent urination (including waking at night to urinate), unexplained weight loss, and blurred vision. Autoimmune adrenal disease (Addison’s disease) may cause low blood pressure, dizziness on standing, salt cravings, darkening of the skin, and profound fatigue. In women, these endocrine changes can also lead to irregular or absent periods, fertility challenges, and pregnancy complications if not recognized and treated.

Digestive System

Autoimmune diseases that affect the gastrointestinal tract can cause abdominal pain, cramping, bloating, chronic diarrhea or constipation, or a combination of both. In inflammatory bowel disease, there may be blood or mucus in the stool, urgency, and nighttime bowel movements. Celiac disease can present with diarrhea, weight loss, iron deficiency, or subtle symptoms such as bloating and fatigue that worsen after eating gluten-containing foods. Some autoimmune liver or stomach conditions may cause early fullness, nausea, right upper abdominal discomfort, or unexplained changes in liver tests.

Nervous System and Brain

Neurologic involvement may present as numbness, tingling, burning, or weakness in specific areas of the body. People may notice dropping objects, tripping, difficulty with balance, or changes in walking patterns. Visual disturbances, such as blurred or double vision, or episodes of vision loss in one eye, can be early signs of diseases, including multiple sclerosis and neuromyelitis optica. Cognitive symptoms may include “brain fog,” slowed thinking, difficulty finding words, problems with short-term memory, and trouble concentrating, which are frequently reported by women with systemic autoimmune conditions and may be misattributed to stress, mood, or aging.

Heart and Lungs

When autoimmune inflammation affects the heart or blood vessels, symptoms may include chest pain with deep breathing, shortness of breath at rest or with exertion, palpitations, or episodes of lightheadedness. Fluid can accumulate around the heart (pericardial effusion) or lungs (pleural effusion), causing a sense of chest pressure or difficulty taking a deep breath. Some conditions also stiffen or scar lung tissue, leading to a gradual decline in exercise tolerance, a persistent cough, or a feeling of “air hunger” disproportionate to routine activity.

In women, autoimmune symptoms frequently intersect with gynecologic and reproductive health. Heavy, painful, or irregular periods; new or worsening premenstrual symptoms; recurrent pregnancy loss; preeclampsia or other pregnancy complications; premature ovarian insufficiency; postpartum flares; and shifting symptom patterns around perimenopause may all reflect underlying autoimmunity rather than hormones alone. Because fatigue, pain, mood changes, and cognitive complaints are often attributed exclusively to stress, anxiety, depression, or “normal” female physiology, women’s concerns can be minimized or fragmented across specialties, which contributes to long delays in diagnosis.

Many autoimmune diseases follow a relapsing–remitting pattern. Symptoms may flare over days, weeks, or months and then partially subside, sometimes giving the false impression that the problem has resolved. Flares can track with infections, hormonal shifts (such as postpartum or perimenopause), major life stressors, medication changes, or environmental exposures. Keeping a record of when symptoms begin, what appears to trigger or alleviate them, and which organ systems are involved helps clinicians recognize an autoimmune pattern instead of treating each symptom in isolation. Any persistent or recurrent combination of unexplained fatigue, pain, rash, neurologic changes, digestive issues, or systemic symptoms should prompt evaluation, particularly in women with personal or family histories of autoimmune disease.

Causes

What are the most common causes associated with autoimmune conditions?

Autoimmune diseases develop when the immune system loses part of its normal tolerance to the body’s own tissues and begins to attack them as if they were foreign. There is no single cause. Most conditions arise from the interaction of inherited susceptibility, sex-related biology, infections, environmental exposures, and lifestyle over time.

Key contributing processes include:

Genetic Susceptibility

Variants in immune-related genes, including HLA types and genes that regulate T and B cells, increase the likelihood of autoimmunity. These patterns tend to cluster in families, which is why one relative may have lupus, another autoimmune thyroid disease, and another type 1 diabetes.

Sex Chromosomes and Hormones

Many immune-related genes reside on the X chromosome. In women, some of these genes can escape normal X-inactivation, potentially leading to stronger or less tightly regulated immune responses. Estrogen and other sex hormones influence how immune cells activate, signal, and recover. Hormonal shifts at puberty, during the menstrual cycle, in pregnancy and postpartum, and around menopause can unmask or amplify underlying autoimmune tendencies.

Infections as Triggers

Certain viral and bacterial infections appear to trigger autoimmunity in genetically susceptible individuals by mimicking human proteins, driving persistent immune activation, or inducing chronic inflammation. Epstein–Barr virus is strongly associated with several autoimmune diseases, and COVID-19 has been linked in some studies to an increased rate of new autoimmune diagnoses in the months after infection.

Environmental and Occupational Exposures

Contact with specific chemicals, pesticides, solvents, silica dust, air pollution, and endocrine-disrupting compounds in consumer products may alter immune regulation and hormone signaling. These exposures can be particularly relevant for women whose immune and endocrine systems are already shifting across reproductive and menopausal stages.

Lifestyle and Metabolic Factors

Smoking is a clear risk factor for several autoimmune diseases, including rheumatoid arthritis, lupus, and multiple sclerosis. Diet, gut microbiome composition, obesity, chronic stress, and sleep disruption also shape immune tone and may influence disease expression and flares, even though their roles vary by condition.

Autoimmune diseases, therefore, reflect a convergence of genetic, hormonal, infectious, environmental, and lifestyle influences rather than a single “cause.” For women, the interplay between sex hormones, X-linked genes, reproductive events, and environmental exposures likely explains a substantial share of the observed sex bias and shapes when and how disease appears.

Risk Factors

What are the most common risk factors associated with autoimmune conditions?

Risk factors do not guarantee that someone will develop an autoimmune disease, but they do increase the likelihood and help determine when a more thorough evaluation is warranted, especially in women who report unexplained or multi-system symptoms that are not improving over time.

Important risk factors include:

Sex at Birth

Being female is one of the strongest risk factors for many autoimmune conditions. Women account for the majority of patients in diseases such as systemic lupus erythematosus, Sjögren’s disease, autoimmune thyroid disease, and scleroderma, and they are also at higher risk for multiple autoimmune diagnoses over a lifetime.

Age and Reproductive Life Stage

Many autoimmune diseases begin between the ages of 20 and 50, which overlap with the prime reproductive years. Puberty, pregnancy, postpartum, and perimenopause are key windows when rapid shifts in estrogen, progesterone, and other hormones interact with the immune system. These stages can reveal new autoimmune diseases, trigger flares of existing conditions, or change how the disease behaves. Postpartum periods and the years around menopause are especially important times to monitor new or worsening symptoms in women with risk factors.

Family History

Having a biological parent, sibling, or child with any autoimmune disease increases the overall risk, even if the specific diagnosis differs among family members. A family pattern that includes multiple autoimmune conditions, early onset of disease, or severe organ involvement suggests a stronger inherited susceptibility and may justify a lower threshold for testing when symptoms appear.

Personal History of Autoimmunity

Having one autoimmune condition raises the likelihood of developing another, sometimes referred to as multiple autoimmune syndrome. For example, autoimmune thyroid disease may coexist with type 1 diabetes, celiac disease, vitiligo, or pernicious anemia. In clinical practice, the presence of one autoimmune diagnosis should prompt clinicians to remain alert to new symptoms that may indicate a second condition, rather than assuming that all symptoms are explained by the first.

Infections and Post-Infectious States

Previous infection with certain viruses and bacteria is associated with a higher risk of specific autoimmune diseases. Epstein–Barr virus, for example, has strong associations with systemic lupus erythematosus, multiple sclerosis, and other conditions. COVID-19 has also been associated with increased autoimmune phenomena and new diagnoses in some cohorts, especially following severe infection. In genetically or hormonally susceptible women, these post-infectious states can act as turning points where vague symptoms consolidate into clearer autoimmune patterns.

Environmental and Occupational Exposures

Long-term exposure to certain chemicals, pesticides, solvents, silica dust, or elevated air pollution, as well as endocrine-disrupting compounds in plastics and personal care products, may increase risk in genetically susceptible individuals. These exposures can alter hormone signaling, immune regulation, or the microbiome. For women, whose endocrine and immune systems are already shifting across reproductive and menopausal stages, these added pressures can be particularly relevant.

Smoking and Nicotine Use

Cigarette smoking and other nicotine exposures increase the likelihood and severity of several autoimmune conditions, including rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis. Smoking can also reduce the effectiveness of some treatments and worsen long-term outcomes, which is why smoking cessation is an important part of autoimmune care.

Metabolic and Lifestyle Factors

Obesity, insulin resistance, and metabolic syndrome contribute to low-grade systemic inflammation and can make autoimmune disease more active, more symptomatic, or harder to control. Diet patterns that are highly processed and low in fiber, physical inactivity, and limited time outdoors (with potential vitamin D deficiency) may further shape risk in some populations, although their exact contributions differ by condition.

Chronic Stress and Sleep Disruption

Chronic psychological stress, trauma, and ongoing high-demand caregiving burdens can alter stress-hormone pathways and immune regulation over time. Many women carry persistent responsibilities at home and work that limit recovery, sleep, and self-care. Long-term stress, untreated anxiety or depression, and fragmented or insufficient sleep can amplify fatigue, pain, and flares in people with established disease and may contribute to the transition from “at-risk” immune patterns to overt autoimmunity in those who are susceptible.

For women, the practical implication is straightforward but often overlooked: persistent, unexplained symptoms should not be dismissed as “just hormones,” “just stress,” or a normal part of aging, especially when one or more of these risk factors are present. Recognizing how sex, life stage, genetics, infections, environment, chronic stress, and lifestyle intersect provides a clearer framework for deciding when to test, when to refer to a specialist, and how urgently to investigate possible autoimmune disease.

Diagnosis and Testing

How do healthcare providers diagnose autoimmune diseases?

Diagnosing an autoimmune disease is rarely a single-test, single-visit process. Most people reach a diagnosis through a combination of history, physical examination, targeted laboratory testing, and, at times, imaging or biopsy, often over several visits and sometimes with input from more than one specialist.

A thorough evaluation usually begins with a detailed conversation. Your provider will ask about:

The full range of your symptoms, including when they began, how they have changed over time, and what makes them better or worse.

Whether symptoms cluster around particular times (for example, around your menstrual cycle, during pregnancy or postpartum, after infections, or around major stressors).

Your past medical history, including prior diagnoses, surgeries, infections, and medications (including hormonal contraception and fertility treatments).

Your family history, especially any autoimmune diseases, early heart disease, unexplained miscarriages, thyroid disorders, type 1 diabetes, celiac disease, inflammatory bowel disease, or “mystery” illnesses in relatives.

The physical examination is tailored to your symptoms but often includes careful assessment of joints, skin, hair and nails, lymph nodes, heart and lungs, abdomen, neurologic function, and signs of endocrine or vascular disease. For women, clinicians should also consider menstrual, pregnancy, and menopausal histories, as pattern changes in these areas can provide important clues.

Autoimmune diseases are typically diagnosed through differential diagnosis, meaning your provider rules out other explanations (such as infection, malignancy, mechanical problems, or isolated mental health conditions) and narrows down the list of possible immune-mediated conditions. Because many autoimmune diseases overlap in symptoms, the initial label may be broad (for example, “undifferentiated connective tissue disease”) and refined over time as more information emerges.

Common laboratory tests include:

General Inflammation and Organ Function Tests

These tests establish whether inflammation is present and whether major organs are being affected:

Complete Blood Count: Evaluates red cells, white cells, and platelets to identify anemia, leukopenia, or thrombocytopenia, which are common in systemic lupus erythematosus, Sjögren’s disease, and some vasculitides. Certain patterns, such as hemolytic anemia, lymphopenia, or immune thrombocytopenia, can point toward specific autoimmune syndromes or treatment side effects. Persistent abnormalities also help determine the urgency of immunosuppression and whether input from bone marrow or hematology is required.
Inflammatory Markers (ESR, CRP): Measure the overall level of inflammatory activity and help track whether the disease is quiescent, flaring, or responding to treatment. Very elevated values are often seen in conditions such as rheumatoid arthritis, giant cell arteritis, polymyalgia rheumatica, inflammatory bowel disease, and systemic vasculitis. Discordant patterns (for example, high ESR with relatively normal CRP in lupus) can also provide diagnostic clues and guide how aggressively to escalate therapy.
Kidney and Liver Panels, Electrolytes, Glucose, and Lipids: Assess organ involvement and detect complications, including lupus nephritis, vasculitic kidney injury, autoimmune hepatitis, primary biliary cholangitis, or treatment-related toxicity. These tests inform safe use and dosing of drugs such as methotrexate, azathioprine, mycophenolate, biologics, and high-dose steroids. Glucose and lipid results also help evaluate cardiometabolic risk, which is often elevated in long-standing inflammatory diseases and shapes preventive care.

Autoantibody and Immune Marker Panels

These tests look for immune “signatures” that support or refine a suspected diagnosis:

Antinuclear Antibody (ANA): Serves as a broad screening test for many connective tissue diseases by detecting antibodies directed against nuclear components. A positive ANA is common in systemic lupus erythematosus, mixed connective tissue disease, systemic sclerosis, and Sjögren’s disease, but can also appear in autoimmune thyroid disease and even in some healthy individuals. The titer and pattern, interpreted alongside symptoms, help determine whether further disease-specific testing is warranted.
Disease-Specific Autoantibodies: Help distinguish among specific connective tissue diseases and predict organ involvement. Anti-dsDNA and anti-Smith strongly support systemic lupus erythematosus and, in the case of anti-dsDNA, correlate with lupus nephritis activity. SSA/SSB are seen in Sjögren’s disease and lupus and are relevant for neonatal lupus and congenital heart block risk in pregnancy, while RNP is characteristic of mixed connective tissue disease. Scl-70 and centromere antibodies help differentiate diffuse from limited cutaneous systemic sclerosis and are associated with interstitial lung disease or pulmonary hypertension, respectively.
Rheumatoid Factor and Anti-CCP Antibodies: Support the diagnosis of rheumatoid arthritis and help distinguish it from osteoarthritis, viral arthritis, and other inflammatory arthritides. Anti-CCP antibodies, in particular, are highly specific and are associated with more erosive joint disease and a higher likelihood of persistent, aggressive arthritis. These markers also inform prognosis and the timing of disease-modifying therapy initiation.
Thyroid Antibodies (TPO, thyroglobulin, TSH receptor): Identify autoimmune thyroid disease and clarify whether the gland is being progressively destroyed or overstimulated. TPO and thyroglobulin antibodies are typical of Hashimoto’s thyroiditis and predict progression to hypothyroidism, while TSH receptor antibodies are characteristic of Graves’ disease and relate to the severity of hyperthyroidism and eye involvement. Their presence also heightens suspicion for additional autoimmune conditions, such as type 1 diabetes or pernicious anemia, in polyglandular syndromes.
Tissue Transglutaminase and Related Antibodies: Detect celiac disease by demonstrating an immune response to gluten that targets the small intestine. High titers, particularly when accompanied by anti-endomysial antibodies and compatible HLA types, strongly support the diagnosis and may reduce the need for immediate biopsy in selected settings. Identifying celiac disease is important not only for gastrointestinal symptoms but also for associated issues such as iron deficiency, bone loss, infertility, and coexisting autoimmune thyroid or liver disease.
Antiphospholipid Antibodies: Are measured when there is a history of blood clots, pregnancy loss, livedo reticularis, or certain neurologic events. Persistent positivity for lupus anticoagulant, anticardiolipin, or anti–β2 glycoprotein I antibodies supports the diagnosis of antiphospholipid syndrome, which can occur alone or with lupus. These results guide decisions about anticoagulation, pregnancy management, and long-term vascular risk reduction.
ANCA and Other Vasculitis Markers: Aid in recognizing and classifying vasculitic syndromes when vessel inflammation is suspected based on symptoms, imaging, or organ findings. Anti–proteinase 3 (PR3) and anti–myeloperoxidase (MPO) ANCA are associated with ANCA-associated vasculitides such as granulomatosis with polyangiitis and microscopic polyangiitis, which can affect the kidneys, lungs, sinuses, and nerves. Complement levels, cryoglobulins, and other immune markers may also be assessed in specific settings to further refine the type and severity of vasculitis and to monitor treatment response.

Autoantibodies are not “yes/no” answers on their own. Some healthy people, especially women, can have low-titer autoantibodies without disease, while some patients with clear clinical autoimmunity test negative early on. Providers interpret these results in context rather than relying on a single test.

Imaging and other studies help define where and how the immune system is causing damage:

X-Rays and Ultrasound

These modalities are frequently used to evaluate joints, soft tissues, and certain organs in a relatively quick and accessible way. Plain X-rays can show erosions, joint space narrowing, deformities, and calcifications that develop in chronic inflammatory arthritis such as rheumatoid arthritis or psoriatic arthritis. Musculoskeletal ultrasound can detect active synovitis, tendon sheath inflammation, bursitis, and small fluid collections that may not be visible on X-ray, and it can guide joint or soft-tissue injections. Abdominal ultrasound helps assess organ enlargement, biliary disease, and vascular complications, including portal hypertension or features suggestive of autoimmune hepatitis, primary biliary cholangitis, or splenic involvement.

MRI or CT Scans

Cross-sectional imaging provides detailed views of internal organs and deep tissues that cannot be adequately assessed with X-ray or ultrasound alone. MRI of the brain and spinal cord is central to evaluating suspected multiple sclerosis and other central nervous system demyelinating diseases, as it reveals lesions that guide diagnosis and treatment decisions. MRI is also used to assess inflammatory myopathies, sacroiliitis in spondyloarthritis, and cardiac or pulmonary involvement in systemic autoimmune diseases. CT scans are often preferred for high-resolution evaluation of the lungs in interstitial lung disease, for identification of vasculitic changes in medium and large vessels, and for assessment of abdominal organs and mesenteric vessels in vasculitis, inflammatory bowel disease, or autoimmune pancreatitis.

Echocardiography or Specialized Cardiac Imaging

Echocardiograms use ultrasound to examine cardiac structure and function, detect pericardial effusions, evaluate valve disease, and assess ventricular performance in conditions such as systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, and myositis. Doppler and strain imaging can reveal subtle dysfunction before symptoms become advanced. In selected cases, more specialized cardiac imaging, such as cardiac MRI or CT angiography, helps characterize myocarditis, coronary vasculitis, pulmonary hypertension, or fibrotic changes that may accompany systemic autoimmune diseases.

Endoscopy or Colonoscopy

Direct visualization of the gastrointestinal tract, along with targeted biopsies, is often required when portal hypertensive changes related to inflammatory bowel disease, celiac disease, autoimmune gastritis, or autoimmune hepatitis are suspected. Upper endoscopy can reveal villous atrophy in celiac disease, inflammatory or atrophic gastritis, and esophageal involvement. Colonoscopy can identify mucosal ulceration, friability, strictures, and pseudopolyps in Crohn’s disease or ulcerative colitis, and biopsies confirm the pattern and severity of inflammation, dysplasia, or microscopic colitis.

Biopsy of Skin, Kidney, Nerve, Muscle, or Salivary Gland

Tissue biopsy is sometimes necessary to confirm a diagnosis, grade disease severity, and choose the most appropriate treatment. Skin biopsy can distinguish among types of vasculitides, cutaneous lupus, dermatomyositis, and other inflammatory dermatoses. Kidney biopsy is critical in systemic lupus erythematosus, ANCA-associated vasculitis, and other immune-mediated nephritides to classify the pattern of injury and guide immunosuppressive intensity. Nerve and muscle biopsies help differentiate inflammatory neuropathies and myopathies from degenerative or metabolic causes. Minor salivary gland biopsy can support a diagnosis of Sjögren’s disease when serologic tests are inconclusive.

Because autoimmune diseases often affect multiple organ systems simultaneously, diagnostic work-up and ongoing assessment usually require coordinated input from primary care clinicians and specialists in rheumatology, neurology, endocrinology, gastroenterology, dermatology, nephrology, cardiology, pulmonology, hematology, and immunology. For women, integrated care with high-risk obstetrics, maternal–fetal medicine, and reproductive endocrinology is particularly important when contraception, fertility, pregnancy, or menopause management must be aligned with autoimmune disease control and immunosuppressive therapy.

Management and Treatment

What treatments are available for autoimmune diseases?

Autoimmune disease management centers on three primary objectives: reducing inappropriate immune activity, controlling inflammation and symptoms, and protecting organs over the long term. There is no single medication that treats all autoimmune conditions, so treatment plans are individualized based on the specific diagnosis, organs involved, disease severity, life stage (including pregnancy plans), and the person’s broader health profile. Most regimens combine immunomodulatory or immunosuppressive medications, targeted symptom-relief strategies, physical and occupational rehabilitation when appropriate, structured mental health support, and lifestyle measures that support overall cardiometabolic and immune health. Common medication categories include:

Analgesics (Pain Relievers)

Over-the-counter or prescription pain medications can help with mild to moderate pain, but they do not treat the underlying immune process. They are usually part of a broader plan rather than a stand-alone solution.

Anti-Inflammatory Medications

Nonsteroidal anti-inflammatory drugs (NSAIDs) can relieve pain and stiffness in conditions like inflammatory arthritis, though they must be used carefully in people with kidney disease, heart disease, or stomach issues.

Corticosteroids (such as prednisone) are powerful anti-inflammatory agents used to quickly control flares or severe organ involvement. Because long-term steroid use carries significant side effects (weight gain, bone loss, diabetes, infection risk, mood changes), clinicians aim to use the lowest effective dose for the shortest time and to transition to safer long-term options when possible.

Disease-Modifying Antirheumatic Drugs (DMARDs) and Immunosuppressants

These medications directly reduce overactive immune responses and help prevent ongoing damage. They include older conventional agents (such as methotrexate, azathioprine, mycophenolate mofetil, and hydroxychloroquine) and newer targeted drugs. They are mainstays for conditions like rheumatoid arthritis, lupus, vasculitis, and many systemic autoimmune diseases. Regular monitoring of blood counts and organ function is necessary to balance the benefits and risks.

Biologic Therapies and Targeted Synthetic Agents

Biologics are engineered molecules that block specific immune pathways, including TNF inhibitors, IL-6 inhibitors, B-cell–depleting therapies, and integrin and cytokine blockers, used in inflammatory arthritis, inflammatory bowel disease, multiple sclerosis, and other conditions. Targeted synthetic drugs, such as JAK inhibitors, act on key signaling pathways inside immune cells. These therapies have transformed outcomes for many autoimmune diseases, but also require careful screening (for infections, latent TB, hepatitis) and ongoing monitoring.

Intravenous Immunoglobulin (IVIG) and Related Therapies

IVIG is a pooled preparation of antibodies that modulate immune responses and is used for certain neurologic autoimmune diseases, immune-mediated thrombocytopenia, and certain connective tissue conditions. In selected cases, plasma exchange (plasmapheresis) or newer therapies targeting IgG recycling may be used to rapidly reduce pathogenic antibodies.

Condition-Specific Treatments

Insulin therapy for type 1 diabetes
Gluten-free diet for celiac disease
Thyroid hormone replacement for autoimmune hypothyroidism or medications to reduce thyroid hormone production in Graves’ disease
Bile duct–targeted therapies and ursodeoxycholic acid in some autoimmune liver conditions
Topical or systemic treatments for psoriasis or vitiligo

Non-medication treatments are equally important:

Physical and Occupational Therapy

These help maintain strength, flexibility, joint protection, and energy conservation. They can teach strategies to adapt work, caregiving, and daily activities when mobility, pain, or fatigue are limiting.

Mental Health Support

Depression, anxiety, trauma, and chronic stress are common among people living with autoimmune disease and can both worsen symptoms and be consequences of long diagnostic delays. Psychotherapy, support groups, and, when indicated, medications can be critical parts of comprehensive care.

Lifestyle and Self-Management

While lifestyle changes cannot “cure” autoimmune disease, they can meaningfully influence symptom control and overall health. This includes smoking cessation; balanced nutrition that supports gut and cardiovascular health; regular physical activity, as tolerated; sleep hygiene; pacing activities to avoid crashes; and strategies to manage chronic stress. For women, planning around flares, caregiving demands, and menstrual or menopausal changes often requires explicit discussion and support.

Reproductive and Preventive Care

For people who are pregnant or planning pregnancy, treatment plans must balance disease control with fetal safety. Some medications must be stopped well before conception; others are considered safer to continue. High-risk obstetric care and preconception counseling are essential when diseases like lupus, antiphospholipid syndrome, myasthenia gravis, or inflammatory bowel disease are present. Vaccinations (including against influenza, pneumonia, and other preventable infections) are another important component of care, particularly for individuals receiving immunosuppressive drugs.

Because immune systems, genetics, comorbidities, and life circumstances differ, treatment is an ongoing process rather than a one-time decision. Plans are adjusted based on how well symptoms respond, how lab and imaging markers change, and how treatments fit with the person’s reproductive goals, work, family responsibilities, and quality of life. The overarching aim is to achieve and maintain the lowest possible level of disease activity, protect organs over the long term, and support a life as full and functional as possible.

Outlook and Prognosis

Can autoimmune diseases be cured?

Autoimmune diseases are generally lifelong conditions. At this time, there is no true “cure” that permanently resets the immune system so that it never attacks the body again. However, that does not mean the outlook is uniformly poor. Prognosis varies widely depending on the specific diagnosis, the organs involved, the stage at diagnosis, and the promptness with which effective treatment is initiated.

Many autoimmune diseases can be brought into low disease activity or remission, in which symptoms are minimal or absent, and markers of inflammation are well controlled. In some conditions, such as rheumatoid arthritis, inflammatory bowel disease, and certain forms of vasculitis, modern therapies have transformed outcomes, sharply reducing rates of permanent joint damage, disability, and major organ failure when treatment is started early and adjusted regularly. In other conditions, such as systemic lupus erythematosus or multiple sclerosis, careful management can substantially reduce flare rates, protect organs such as the kidneys and brain, and allow many people to work, parent, and live full lives, even though the underlying tendency toward autoimmunity persists.

Remission in this context means a sustained period with few or no symptoms and little evidence of active inflammation. It is not the same as a cure, because the disease can reactivate under stress, infection, hormonal shifts, or medication changes. Still, long, stable remissions can dramatically reduce the impact of the disease on daily life, relationships, pregnancy, and aging. For women, effective control of autoimmunity can also improve fertility options, pregnancy safety, and menopausal transitions, which are all more complicated when inflammation is uncontrolled.

On the other end of the spectrum, delayed diagnosis, inadequate treatment, or poor access to care can allow ongoing inflammation to scar joints, organs, nerves, or blood vessels. This can lead to chronic pain, mobility limitations, organ failure, or increased risk of heart attack and stroke. Mental health burdens, including depression, anxiety, trauma from medical encounters, and the cumulative strain of being unwell but not believed, also shape long-term outcomes and must be addressed as part of the prognosis.

In practical terms, most people with autoimmune disease will live with the condition for decades. The key questions are: How active will it be? How well will organs be protected? And how well-supported will the person be in navigating work, caregiving, reproductive decisions, and aging with a chronic illness? Early recognition, access to appropriate specialists, individualized treatment (including during pregnancy or menopause), and ongoing adjustments over time can shift the trajectory toward better function, fewer complications, and a more predictable long-term course, even in the absence of a cure.

Prevention

Can you prevent autoimmune diseases?

There is currently no guaranteed way to prevent autoimmune diseases altogether, because no single cause has been identified, and many risk factors (such as genetics, sex at birth, and some early-life exposures) cannot be changed. A person can do “everything right” and still develop an autoimmune disease, which is important to name clearly so that individuals do not blame themselves.

That said, there are meaningful opportunities for risk reduction and early intervention, particularly for people with known risk factors such as a strong family history, prior autoimmune disease, or certain infections or environmental exposures.

While we cannot reliably stop autoimmunity from ever starting, you and your clinicians can focus on:

Reducing Modifiable Triggers

Avoiding cigarette smoking and other nicotine products, limiting unnecessary exposure to known harmful chemicals and industrial solvents when possible, and addressing air quality and occupational risks can lower the burden on an already susceptible immune system. Managing weight, blood pressure, and metabolic health reduces baseline inflammation that may exacerbate disease expression once it manifests.

Protecting Against Severe Infections

Vaccination, prompt treatment of infections, and basic infection-prevention measures may reduce the risk of infectious “triggers” that can unmask autoimmunity in genetically susceptible people. This is especially relevant for women in healthcare, caregiving, teaching, and other roles with high exposure to respiratory and viral illnesses.

Managing Chronic Stress and Sleep Deprivation

Long-term psychological stress, trauma, and sustained sleep disruption can alter immune regulation. While these factors are not the sole causes, addressing them through therapy, social support, boundary-setting, and sleep-focused strategies can help maintain more stable immune activation and may reduce the frequency and severity of disease flares in individuals with the disease.

Monitoring High-Risk Groups More Closely

For women with strong family histories of autoimmunity, prior postpartum flares, recurrent pregnancy loss, premature ovarian insufficiency, or a personal history of one autoimmune disease, regular check-ins and low thresholds for testing when new symptoms arise function as a form of secondary prevention. The aim is to detect emerging autoimmunity earlier, when organ damage is still limited, thereby enabling more effective treatment.

Building A Preventive Care Framework Around Women’s Life Stages

Integrating autoimmune risk awareness into routine gynecologic and primary care visits, particularly around puberty, preconception counseling, pregnancy, postpartum, and perimenopause, can help clinicians recognize patterns that might otherwise be written off as “just hormones.” This does not prevent all autoimmune diseases, but it does help prevent years of unrecognized, untreated inflammation.

In summary, autoimmune diseases themselves cannot yet be reliably prevented. However, modifying environmental and lifestyle risk factors where possible, protecting against severe infections, actively managing chronic stress, and taking women’s early warning symptoms seriously can lower overall risk and, critically, reduce the chance of late diagnosis and irreversible damage. Prevention in autoimmunity is as much about early recognition and organ protection as it is about trying to stop disease from occurring in the first place.

Living with Autoimmune Diseases

How can patients take the best care of themselves following an autoimmune diagnosis?

Living with an autoimmune disease is less about following a single rulebook and more about learning how your specific body behaves over time. The core goal is to keep disease activity as low as possible while protecting your joints, organs, energy, and quality of life.

Most people need a combination of:

Regular Medical Follow-Up

Ongoing visits with your primary clinician and, when needed, specialists such as rheumatologists, neurologists, endocrinologists, gastroenterologists, or dermatologists. For women, this often includes close coordination with gynecology, high-risk obstetrics, or reproductive endocrinology when planning pregnancy or navigating perimenopause and menopause.

Medication Adherence and Monitoring

Taking prescribed medications consistently and completing recommended laboratory tests and imaging so your team can assess how well treatments are working and adjust them before harm accumulates.

Energy Management and Activity Pacing

Matching your activity level to your current reserves instead of pushing until you crash. Many people benefit from scheduling demanding tasks for times of day when they are most alert, breaking chores into smaller steps, and incorporating rest periods to mitigate fatigue and pain.

Thoughtful Movement

Gentle, regular physical activity helps preserve joint range of motion, muscle strength, cardiovascular health, and mood. The “right” level varies by individual and diagnosis and may change during flares, so it is advisable to ask for specific exercise guidance or physical therapy rather than avoiding movement altogether out of fear.

Nutrition and Metabolic Health

There is no single autoimmune diet, but patterns that support gut and cardiovascular health, maintain stable blood sugar, and provide adequate protein are generally beneficial. Some conditions require specific approaches, such as strict gluten avoidance in celiac disease or carbohydrate management in type 1 diabetes.

Sleep and Stress Care

Prioritising realistic sleep routines and addressing chronic stress, trauma, anxiety, or depression is not optional “self-care.” These factors directly influence symptom severity, coping capacity, and inflammation over time.

Self-Advocacy

Keeping your own records, tracking symptoms and triggers, bringing questions to visits, and saying clearly when things are not improving are all part of living with a long-term immune condition. For women, whose symptoms are often minimised or fragmented across different specialties, this advocacy is especially important.

Your exact mix of strategies will change with life stage, work and caregiving demands, pregnancy planning, and how active your disease is at any given time. The plan should feel like a collaboration, not something done to you.

Severity

Is an autoimmune disease serious?

An autoimmune diagnosis always warrants serious consideration, but seriousness does not mean hopelessness. Some conditions are relatively mild, primarily affecting the skin or joints, and respond well to standard therapies with minimal long-term organ damage. Others can inflame vital organs such as the kidneys, lungs, heart, nervous system, or large blood vessels and may cause permanent damage or become life-threatening if they are not recognised and treated early.

Several factors shape how “serious” a given disease is in practice:

Which Organs Are Involved

A disease that affects vital organs such as the kidneys, brain, spinal cord, heart, lungs, or major blood vessels carries a higher risk of permanent damage and life-threatening complications than a disease limited to skin, joints, or glands.

How Aggressive the Immune Response Is

Some autoimmune processes are smoldering and slow, causing gradual changes over years, whereas others are rapidly progressive, leading to acute organ failure or widespread inflammation over days to weeks. The pace and intensity of inflammation strongly influence risk.

How Early Treatment Begins

Conditions identified in their early stages can often be controlled before significant scarring or structural damage occurs. Delayed diagnosis allows inflammation to accumulate and can limit the extent to which function can be restored, even when treatment becomes effective later.

How Consistently the Disease is Monitored and Managed

Regular follow-up, timely medication adjustments, laboratory and imaging surveillance, and attention to flares and complications all reduce the risk of sudden deterioration. Gaps in care, treatment interruptions, or lack of access to specialist input increase long-term risk.

What Other Conditions Are Present

Coexisting cardiovascular disease, high blood pressure, diabetes, chronic kidney disease, lung disease, chronic infections, or obesity can amplify the impact of autoimmunity, increase treatment risks, and raise the probability of serious complications such as heart attack, stroke, or severe infection.

Conditions such as systemic lupus erythematosus, systemic vasculitis, inflammatory myopathies, multiple sclerosis, and autoimmune encephalitis can be life-threatening if they are severe and left uncontrolled. They can damage kidneys, lungs, nerves, muscles, or the brain, and in some cases can progress quickly. At the same time, advances in immunomodulatory therapies, better monitoring tools, and multidisciplinary care have significantly improved survival and reduced long-term disability when these diseases are recognised early and treated in centres with appropriate experience. Other autoimmune conditions, such as autoimmune thyroid disease, vitiligo, and limited cutaneous systemic sclerosis, may cause substantial symptoms, distress, and quality-of-life impairment, but rarely threaten life directly when properly managed.

For women, seriousness also includes how disease intersects with reproductive and hormonal health. Active systemic autoimmunity can increase the risk of pregnancy loss, preeclampsia, fetal growth restriction, and blood clots, particularly when inflammation or autoantibodies are not controlled before conception. Some medications used to treat autoimmune disease are not safe in pregnancy and must be adjusted or replaced in advance. With preconception counselling, careful medication planning, and coordinated high-risk obstetric care, many women with autoimmune conditions have safe pregnancies and healthy babies. Similarly, decisions about contraception, hormone therapy, and menopause management are more complex in the setting of autoimmunity and require individualised risk–benefit discussions.

Life Expectancy

What is the life expectancy of someone with an autoimmune disease?

It is difficult to give a single estimate of how an autoimmune disease will affect life expectancy, because “autoimmune disease” covers a broad spectrum. Some diagnoses, if mild and well-controlled, have little effect on longevity. Others can shorten lifespan if inflammation is severe, organ damage accumulates, or complications such as infections, blood clots, or cardiovascular disease are not prevented.

In general:

Conditions such as type 1 diabetes, systemic lupus erythematosus, vasculitis, myositis, and multiple sclerosis carry the potential for serious complications. When they are poorly controlled or diagnosed late, they can reduce life expectancy.
With current therapies and close follow-up, many people now live for decades with these diagnoses, often with normal or near-normal life spans, especially when cardiovascular risk factors (like high blood pressure, high cholesterol, smoking, and diabetes) are aggressively managed.
Autoimmune diseases that primarily affect the skin or thyroid function can still impair quality of life but do not necessarily shorten lifespan when appropriately treated.

Individual prognosis depends on the specific diagnosis, the stage at which it was detected, the body's response to treatment, the organs affected, and the management of other health risks. Your clinician, who can see the full picture of your disease activity, organ involvement, treatment response, and life circumstances, is the best person to discuss life expectancy in a meaningful way.

Patient-Provider Community

When should I see my healthcare provider?

You should seek medical evaluation if:

If you develop new or worsening symptoms you cannot explain, especially if they affect more than one body system or interfere with daily activities.
You notice patterns suggestive of autoimmunity, such as prolonged morning stiffness, recurrent mouth ulcers, rashes that worsen with sunlight, episodes of numbness or weakness, unexplained weight changes, or ongoing fatigue that does not improve with rest.
You have an autoimmune diagnosis, and it feels as if your current treatments are no longer working, your flares are becoming more frequent or severe, or you develop new symptoms that do not fit what you have experienced before.

For women, it is especially important to raise concerns when symptoms cluster around reproductive transitions (such as postpartum or perimenopause) or when you experience recurrent pregnancy complications, premature ovarian insufficiency, or menstrual changes combined with systemic symptoms.

Seeking Care

When should I go to the emergency room?

Some symptoms require urgent assessment because they may signal a severe flare, organ-threatening complication, or another emergency. You should go to the emergency department or call 911 (or your local emergency number) if you experience:

Sudden trouble breathing or shortness of breath at rest
Severe chest pain or pressure, especially if it radiates to the arm, jaw, or back
A sudden, severe headache that feels unusual for you or is accompanied by neurologic changes
Sudden weakness, numbness, or difficulty speaking, seeing, or walking, which could indicate stroke or major neurologic involvement
Dizziness or fainting that does not resolve quickly
Pain so severe that you cannot stand, move, or find any position of relief
High fever, shaking chills, or signs of serious infection, particularly if you are on immunosuppressive therapy

If you are unsure whether a symptom is serious enough for the emergency room, err on the side of caution, especially if you have a known autoimmune disease that affects vital organs or you take medications that weaken your immune system.

Patient-Provider Community

Which questions should patients ask their healthcare provider?

Clarifying questions can help you understand your diagnosis and feel more in control of your care. You may want to ask:

Which specific autoimmune disease do you think I have, and what other possibilities are you considering?
Which tests are you ordering now, and what questions are you hoping they will answer?
Does my family history suggest a higher risk for other autoimmune conditions?
What treatments are you recommending now, and what are their goals (for example, symptom relief, slowing damage, or inducing remission)?
How will we monitor whether treatment is working, and how often should I be seen?
How might this condition and its treatment affect my fertility, contraception options, pregnancy, breastfeeding, or menopause management?
What changes, if any, should I make to my daily routine, work, exercise, and diet?
What symptoms or changes should prompt me to contact you sooner than my next scheduled appointment?

It can be helpful to write questions in advance, bring a summary of your symptoms and history, or have a trusted support person accompany you during visits.

Living with Autoimmune Disease

How will my life change following an autoimmune disease diagnosis?

Living with an autoimmune condition is demanding, and it often remains invisible to others. Fatigue, pain, cognitive fog, and the work of managing medications and appointments can all coexist with jobs, caregiving, and the emotional weight of having a chronic illness. None of that is a personal failure or a lack of resilience; it is the reality of navigating a long-term immune disorder in a world that often expects people to carry on as if nothing has changed.

You are not defined solely by your diagnosis. Over time, many people develop a deep understanding of their bodies, boundaries, and needs and build a care team and support network that respects that expertise. The combination of evidence-based medical care, informed self-advocacy, realistic pacing, and emotional support does not erase the difficulty of living with autoimmunity, but it does make it more possible to shape a life that is about more than illness.

The IWBCA provides the information and materials on this site for educational and informational purposes only. The content is not a substitute for professional medical evaluation, diagnosis, or treatment. Always consult your physician or another qualified healthcare provider regarding any questions you may have about a medical condition, diagnosis, or course of treatment. Do not disregard, delay, or alter medical advice based on information obtained from this site. If you believe you are experiencing a medical emergency, call 911 or your local emergency services immediately.